Company Overview
| Stock Name | CR Medical |
|---|---|
| Stock Code | 01515 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 本集团是中国最大的私立医院集团,通过健宫医院提供综合医院服务,以IOT模式管理和运营多家医院及诊所并收取管理费,同时为医院网络提供药品、医疗器械及医用耗材的供应链业务。 |
| Listing Date | 2013-11-29 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 北京西城區太平街6號E-825 |
| Business Address (Hong Kong) | 香港金鐘道88號太古廣場二座1214-1215室 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | phg.com.cn |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 7.38 / shares |
| Offer Price Range | To be extracted |
| Lot Size | 500 shares |
| Entry Threshold | To be extracted |
| Par Value | RMB 0.00025 / shares |
| Offer Period | 2013-11-18 to 2013-11-21 |
| Global Offering Shares | 200,907,000 shares |
| HK Public Offer Shares (Initial) | 20,091,000 shares (10.0%) |
| Public Offer Lots (Initial) | 40,182lots (Pool A20,091lots,Pool B20,091lots) |
| International Placing Shares (Initial) | 180,816,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 803,627,000 shares |
| Greenshoe (Over-allotment Option) | No |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 1,482,693,660 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 3.47B |
| Est. Threshold | HK$ 9.69B |
| Analysis Result | HK market cap below threshold, need +179% |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利约人民币1.107亿元 |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | ~HK$ 107,000,000 |
| Listing Expenses / Funds Raised | ~7.22% |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2010 | 2011 | 2012 | 2013-06 |
|---|---|---|---|---|
| Revenue | 394,085 | 509,478 | 758,032 | 419,692 |
| Cost of sales | -301,164 | -386,729 | -573,228 | -332,268 |
| Gross profit | 92,921 | 122,749 | 184,804 | 87,424 |
| Other income and gains, net | 2,735 | 8,286 | 37,584 | 27,545 |
| Selling and distribution expenses | -834 | -3,426 | -6,412 | -4,747 |
| Administrative expenses | -25,663 | -29,326 | -43,500 | -25,107 |
| Net finance costs | -2,997 | -18,858 | -24,379 | -11,531 |
| Profit before tax | 65,032 | 78,718 | 147,278 | 70,161 |
| Income tax expense | -16,023 | -20,217 | -36,544 | -17,745 |
| Profit for the year | 49,009 | 58,501 | 110,734 | 52,416 |
| Profit attributable to owners | 42,812 | 48,130 | 101,088 | 50,354 |
Balance Sheet
| Item | 2010 | 2011 | 2012 | 2013-06 |
|---|---|---|---|---|
| Cash and cash equivalents | 74,675 | 330,988 | 113,124 | 128,246 |
| Trade and bills receivables | 20,100 | 23,845 | 83,010 | 110,518 |
| Inventories | 22,267 | 23,200 | 35,073 | 30,249 |
| Total current assets | 409,821 | 489,798 | 365,211 | 535,549 |
| Total assets | 664,310 | 1,134,678 | 1,020,860 | 1,184,400 |
| Total current liabilities | 144,835 | 328,286 | 202,369 | 565,681 |
| Total liabilities | 357,424 | 338,739 | 443,102 | 804,710 |
| Total equity | 306,886 | 795,939 | 577,758 | 379,690 |
| Equity attributable to owners | 283,261 | 591,779 | 485,256 | 285,126 |
| Interest-bearing borrowings | 200,000 | 200,000 | 233,074 | 231,765 |
Cash Flow Statement
| Item | 2010 | 2011 | 2012 | 2013-06 |
|---|---|---|---|---|
| Net cash from operating activities | 70,057 | 62,352 | 166,419 | 72,065 |
| Net cash from investing activities | -328,099 | -36,120 | -102,200 | -58,076 |
| Net cash from financing activities | 298,011 | 230,081 | -282,083 | 1,598 |
| Net increase in cash | 39,969 | 256,313 | -217,864 | 15,587 |
| Depreciation of PP&E | 16,057 | 14,707 | 20,325 | 10,466 |
| Amortisation of intangible assets | 1,516 | 3,168 | 12,376 | 6,945 |
| Purchase of PP&E | -17,157 | -34,347 | -28,115 | -6,664 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 10.0 |
|---|---|
| First Day Open | HK$ 8.58 |
| First Day Change | 35.50% |
| First Day Volume | 210640000.0 |
| First Day Turnover | 1968700000.0 |
| Use of Proceeds | 1、募集資金凈額的42%或58100萬元,將為本集團醫院網絡的擴展(透過公私合營和收購進行,以北京為策略重點)提供資金
2、募集資金凈額的25%或34000萬元,將就Speed Key Limited向債券持有人發行的可交換債券,以12%的年利率悉數償還本集團主要股東Speed Key Limited的未償還貸款
3、募集資金凈額的10%或10100萬元,將在2015年前作出資本支出,為健宮醫院重建若干設施及購買醫療設備
4、募集資金凈額的7%或34000萬元,將在2015年前,在集團層面建立先進的臨床測試及實驗中心
5、募集資金凈額的6%或8000萬元,將在2015年前向燕化醫院集團支付資本承擔
6、募集資金凈額的10%或13800萬元,將用于營運資金及其他一般企業用途 |
Underwriting Syndicate
Overall Coordinators (2)
Joint Bookrunners (3)
Joint Lead Managers (3)
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 梁洪澤 | — |
| Company Secretary | 柯永基 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 徐小捷女士通过Speed Key Limited持股34.51%,朱志偉先生通过升萬投資等持股22.29%,梁洪澤先生通过Hyde International持股7.76%,Greenwoods Bloom Fund通过Green Talent持股7.31%。 |
|---|




